Physical Therapy for Parkinson's Disease
This trial will compare physical therapy alone to physical therapy plus medication (either low dose methylphenidate or atomoxetine) to see if the addition of medication leads to more improvement in gait and balance in patients with Parkinson disease.
- Parkinson's Disease
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the aggregate populace of participants taking part in this research?
"Affirmative. The medical trial is actively looking for participants, as evidenced by the information on clinicaltrials.gov which was last updated February 15th 2022 - shortly after being posted December 1st 2016. 42 patients are sought from a single location to take part in this study."
Who has the necessary qualifications for taking part in this research project?
"This medical trial is seeking 42 individuals suffering from Parkinson's Disease, aged 18-90. To be considered for enrolment, patients must have a score of 2 or higher in the UPDRS 3.10 item 'independent walking but with substantial gait impairment; not related to off periods'. Furthermore, their dopaminergic treatment must remain consistent during the next month."
Are there enrollment opportunities for this clinical exploration at present?
"Per the details available on clinicaltrials.gov, this investigation is presently enrolling participants in its research cohort. The trial was initially published online on December 1st 2016 and recently updated February 15th 2022."
What have prior research efforts divulged about the combination of Physical Therapy and Atomoxetine?
"At present, 4 Phase 3 trials investigating the combination of Physical Therapy and Atomoxetine are ongoing. There is a concentration of studies centered in Houston, Texas but altogether there are 126 locations running this clinical research."
Are individuals over 85 years of age being accepted into this research program?
"This clinical trial has established that 18 is the minimum age of participation, while 90 years old represent the cut-off for qualifications."